Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of two FBS0701 dose levels for chronic transfusional iron overload
2011-005675-16Phase 2Terminated
- Sponsor
- FerroKin BioSciences
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferitazole in transfusional hemosiderosis, sponsored by FerroKin BioSciences. Started Aug 2012; status: terminated.
02
Drugs
deferitazole
03
Conditions
transfusional hemosiderosis
Beyond the preview
Go deeper on 2011-005675-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005675-16.